IRIS
LUNGHI, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.479
AS - Asia 7.895
EU - Europa 5.415
SA - Sud America 866
AF - Africa 338
Continente sconosciuto - Info sul continente non disponibili 105
OC - Oceania 8
Totale 23.106
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.222
SG - Singapore 2.913
CN - Cina 2.400
VN - Vietnam 1.079
IE - Irlanda 886
FI - Finlandia 885
IT - Italia 828
DE - Germania 738
SE - Svezia 707
BR - Brasile 686
HK - Hong Kong 537
UA - Ucraina 478
TR - Turchia 329
NL - Olanda 249
FR - Francia 228
ZA - Sudafrica 213
CA - Canada 170
IN - India 156
GB - Regno Unito 143
BD - Bangladesh 116
RU - Federazione Russa 62
AR - Argentina 57
JP - Giappone 57
CI - Costa d'Avorio 45
IQ - Iraq 43
MX - Messico 37
AT - Austria 33
ES - Italia 32
PL - Polonia 32
EC - Ecuador 30
KR - Corea 30
ID - Indonesia 27
PH - Filippine 27
PK - Pakistan 25
BE - Belgio 21
RO - Romania 21
VE - Venezuela 21
CO - Colombia 19
CL - Cile 18
DZ - Algeria 17
LT - Lituania 17
MA - Marocco 17
UZ - Uzbekistan 17
EU - Europa 16
IR - Iran 16
SA - Arabia Saudita 16
TH - Thailandia 16
PY - Paraguay 14
CZ - Repubblica Ceca 13
EG - Egitto 13
JO - Giordania 13
JM - Giamaica 10
TW - Taiwan 10
UY - Uruguay 9
CR - Costa Rica 8
DO - Repubblica Dominicana 8
AE - Emirati Arabi Uniti 7
BO - Bolivia 7
KE - Kenya 7
NP - Nepal 7
TN - Tunisia 7
AZ - Azerbaigian 6
CH - Svizzera 6
MY - Malesia 6
ET - Etiopia 5
GE - Georgia 5
IL - Israele 5
PE - Perù 5
AU - Australia 4
HN - Honduras 4
HR - Croazia 4
HU - Ungheria 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LU - Lussemburgo 4
LV - Lettonia 4
NZ - Nuova Zelanda 4
OM - Oman 4
PA - Panama 4
BG - Bulgaria 3
BH - Bahrain 3
EE - Estonia 3
LB - Libano 3
LY - Libia 3
MD - Moldavia 3
PT - Portogallo 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
AM - Armenia 2
DK - Danimarca 2
GT - Guatemala 2
KH - Cambogia 2
LC - Santa Lucia 2
LK - Sri Lanka 2
MQ - Martinica 2
SN - Senegal 2
SY - Repubblica araba siriana 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
Totale 22.995
Salva come PNG Salva come JPEG
Città #
Singapore 1.308
San Jose 899
Dublin 887
Jacksonville 727
Ashburn 685
Chandler 667
Beijing 591
Hong Kong 518
Santa Clara 412
Dearborn 394
Council Bluffs 374
Ho Chi Minh City 330
Dallas 309
Boardman 285
Nanjing 279
Izmir 275
San Mateo 239
Hanoi 231
Ann Arbor 217
Johannesburg 202
Princeton 202
Lauterbourg 169
Munich 163
Parma 152
Wilmington 150
Los Angeles 145
Helsinki 134
Pittsburgh 125
Toronto 113
Shenyang 112
New York 103
Hefei 100
Shanghai 87
Jinan 85
Kunming 85
Nanchang 83
Hebei 74
São Paulo 60
Buffalo 56
Changsha 55
Haiphong 54
Bologna 53
Tianjin 53
Jiaxing 50
Düsseldorf 49
Tokyo 47
Grafing 46
Milan 46
Abidjan 45
Seattle 45
Woodbridge 45
Guangzhou 40
Da Nang 39
Columbus 35
Moscow 35
Rio de Janeiro 33
Zhengzhou 32
Des Moines 31
Houston 30
Pune 30
Kocaeli 29
Turku 29
Warsaw 29
Atlanta 28
Norwalk 28
London 26
Rome 26
Hangzhou 25
Montreal 25
Brooklyn 22
Nuremberg 22
Baghdad 21
Brussels 21
Chennai 21
Fremont 21
Leawood 21
Bremen 20
The Dalles 20
Boston 19
Hải Dương 19
Phoenix 19
Augusta 18
Frankfurt am Main 18
Lanzhou 18
Ningbo 18
Taizhou 18
Denver 17
Haikou 17
Orem 17
San Francisco 17
Stockholm 17
Amsterdam 16
Bengaluru 16
Falls Church 16
Seoul 16
Belo Horizonte 15
Chengdu 15
Mexico City 15
Poplar 15
Tashkent 15
Totale 13.725
Salva come PNG Salva come JPEG
Nome #
2,6-Diacetylpyridine bis(thiosemicarbazones) zinc complexes: synthesis, structure, and biological activity 326
Functional interplay between NIK and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma 313
Endocanalicular transendothelial crossing (ETC): A novel intravasation mode used by HEK-EBNA293-VEGF-D cells during the metastatic process in a xenograft model 276
MEK1/2 KINASES DISABLE THE TUMOR SUPPRESSOR FUNCTIONS OF NATIVE BCR AND ABL1 KINASES TO IMPAIR ANTICANCER DRUGS’ RESPONSIVENESS IN TKI-RESISTANT PHILADELPHIA POSITIVE LEUKEMIAS 273
MEK-INHIBITORS/ARSENIC TRIOXIDE COMBINATION THERAPY AS A NOVEL TREATMENT OPTION FOR TYROSINE KINASE INHIBITORS-RESISTANT PH+-LEUKEMIA 257
The Pharmacological Blockade of Phosphodiesterase IV Potentiates the Anti-Tumor Effects of Arsenic Trioxide (ATO) in Acute Myelogenous Leukemia Cells through Multiple Signaling Pathways 231
Acenaphthenequinone Thiosemicarbazone and Its Transition Metal Complexes: Synthesis, Structure, and Biological Activity 227
A translational perspective of the malignant hematopoietic proteoglycome 196
Activation of JNK/SAPK in acute myelogenous leukemia blast cells by anti-leukemic drugs 189
Hypoxia and hypoxia inducible factor (HIF)-1α in Multiple Myeloma patients: role in the angiogenic switch 187
Attività biologica del tiosemicarbazone del piridossale e dei suoi complessi di rame 183
Hypoxia and Hypoxia Inducible Factor (HIF)-1{alpha} in Multiple Myeloma: Effect on the Pro-Angiogenic Signature of Myeloma Cells and the Bone Marrow Microenvironment 177
Alpha and Gamma interferons do not modulate the levels of JNK/SAPK activation in Ph+ leukemic cell lines 176
Activation of JNK/SAPK in acute myelogenous leukemia blast cells by anti-leukemic drugs 175
: Expression and activation of SHC/MAP kinase pathway in primary acute myeloid leukemia blasts 174
Alpha and gamma interferons do not modulate the levels of JNK/SAPK activation in PH+ leukemic cell lines 174
Activation of SHC and ERK kinase pathways in acute myelogenous leukemia 173
Air purification and indoor biologic pollutants 172
L'attività della wortmannin inibitore della fosfatidilinositolo-3 chinasi su cellule di leucemia mieloide cronica in fase cronica 169
Acenaphthenequinone thiosemicarbazone and its transition metal complexes: synthesis, structure and biological activity 169
Acenaphthenequinone thiosemicarbazone and its transition metal complexes: synthesis, structure, and biological activity. 169
Early proinflammatory activation of renal tubular cells by normal and pathologic IgG 157
Aurora and IKK kinases cooperatively interact to protect multiple myeloma cells from Apo2L/TRAIL 156
Acenapthenequinone thiosemicarbazone and its transition metal complexes. Synthesis, structure and biological activity 153
Alpha and gamma interferons do not modulate the levels of JNK/SAPK activation in PH+ leukemic cell lines 151
Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis 151
Activation of SHC and ERK kinase pathways in acute myelogenous leukemia 151
Pro-angiogenetic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 149
MEK-INHIBITORS/ARSENIC TRIOXIDE COMBINATION THERAPY AS A NOVEL TREATMENT OPTION FOR TYROSINE KINASE INHIBITORS-RESISTANT PH plus -LEUKEMIA 148
The new tumor suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of pro-angiogenic molecules by myeloma cells and suppresses hypoxia inducible factor (HIF)-1{alpha} activity being involved in myeloma-induced angiogenesis. 146
Analisi dei meccanismi di attivazione di SHC, ERK e JNK in leucemia acuta mieloide 143
An abatement of the concentration of mycophytes, dust mites and pollens grains in the indoor environment using an air purifier 142
2,6-Diacetylpyridine Bis(Thiosemicarbazones) Zinc Complexes: Synthesis, Structure, and Biological Activity 142
Fosforilazione in tirosina delle proteine adattatrici SHC ed attivazione di ERK-JNK/SAPK kinasi in leucemia acuta mieloblastica 142
p73 and p53 pathway in human breast cancers. 140
Treatment with Arsenic Trioxide (ATO) and MEK1 inhibitor activates the p73-p53AIP1 apoptotic pathway in leukemia cells 138
Human myeloma cells produce angiopoietin-1 but not angiopoietin-2: potential relationship with myeloma-induced angiogenesis 136
An abatement of the concentration of mycophytes, dust mites and pollen grains in the indoor environment using an air purifier 135
Human myeloma cells production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 133
Emerging MEK inhibitors 133
Transition-Metal Complexes of Isatin-beta-Thiosemicarbazone. X-Ray Crystal Structure of Two Nickel Complexes 133
Tyrosine-phosphorylation of SHC adaptor proteins and activation of ERK-JNK/SAPK MAP kinases in acute myelogenous leukemia 131
Emerging Raf inhibitors 130
L'inibizione della proliferazione indotta dal tiosemicarbazone della 2-piridina carbossialdeide e dai relativi complessi di stagno in linee cellulari umane e in cellule derivate da pazienti leucemici è associata ad apotosi 130
Arsenic Trioxide (ATO) and MEK1 inhibition synergize to induce apoptosis in acute promyelocytic leukemia cells 129
Combined treatment with the MEK inhibitor PD0325901 and Arsenic Trioxide has potent anti-tumor activity in vivo against human multiple myeloma xenograft model. 128
Down-Modulation of Erk Protein Kinase Activity Inhibits Vascular Endothelial Growth Factor (VEGF) Secretion by human Myeloma Cell Lines 126
Downmodulation of ERK activity inhibits the proliferation and induces the apoptosis of primary acute myelogenous leukemia blasts 126
Arsenic trioxide in hematological malignancies: The new discovery of an ancient drug 124
MDM2 inhibition synergistically enhances cytotoxicity of MEK1 inhibitor and Arsenic Trioxide (ATO) in AML blasts that retain a functional p53 pathway 122
The ontogenesis of BCL2 oncogen protein in human hemopoietic development 122
Arsenic Trioxide in hematological malignancies: the new discovery of an ancient drug. 121
BCL2 oncogene protein expression in human hematopoietic precursors during fetal life. 121
Human myeloma cells production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 121
VASCULAR ENDOTHELIAL GROWTH FACTOR SECRETION BY MYELOMA CELLS IS INHIBITED BY DOWN-MODULATING ERK PROTEIN KINASE ACTIVITY 120
Pan-aurora kinase inhibitor MK-0457 synergistically potentiates Apo2l/TRAIL cytotoxicity in Multiple Mieloma cells sensitive and resistant to bortezomib 119
MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia 118
Acetylation of core histone tails in cord blood hematopoietic progenitors 118
Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia 118
High levels of ERK constitutive activity in acute myelogenous leukemia 118
p29ING4 regulates the production of pro-angiogenic molecules by human myeloma cells in normoxic and hypoxic conditions being involved in myeloma-induced angiogenesis. 117
Down-modulation of ERK protein kinase activity suppresses human myeloma cell proliferation and myeloma-induced angiogenesis by VEGF inhibition 116
Selective inhibition of MEK1 kinase down-modulates ERK activity and proliferation of acute myeloid leukemia blasts 116
Expression and activation of SHC/MAP kinase pathway in primary acute myeloid leukemia blasts. 113
An abatment of the concentration of mycophytes and pollen grains in the indoor environment using an air purifier 113
Le IgG normali e quelle di soggetti con lupus eritematoso sistemico esercitano un effetto pro-infiammatorio precoce su cellule tubulari umane 112
MEK-ERK pathway is expressed but not activated in high proliferating, self-renewing cord blood hematopoietic progenitors 111
MEK1 inhibition sensitizes primary acute myelogenous leukemia to arsenic trioxide-induced apoptosis 111
Tyrosine phosphorylation of SHC adaptor proteins in chronic myelogenous leukemia 110
High levels of p52/p46 SHC tyrosine-phosphorylation in CD34+ acute myelogenous leukemia 110
Resistance of multiple myeloma cells to trail is overcome by blockade of aurora kinases 110
The p53 family protein p73 provides new insights into cancer chemosensitivity and targeting 110
Synthesis, characterisation, X-ray structure and biological activity of three new 5-formyluracil thiosemicarbazone complexes 109
Attività biologica dei tiosemicarbazoni dell'acido alfa-chetoglutarico e della 2,6 diacetilpiridina 108
Down-modulation of ERK protein kinase activity inhibits vascular endothelial growth factor (VEGF) secretion by human myeloma cell lines 108
Selective inhibition of MEK1 kinase downmodulates ERK activity and proliferation of acute myeloid leukemia blasts 107
Selective expression and constitutive phosphorylation of SHC proteins [corrected] in the CD34+ fraction of chronic myelogenous leukemias 106
Riduzione della concentrazione di micofiti, pollini e allergeni della polvere in ambienti confinati 106
Riduzione di allergeni indoor con purificatore d’aria 104
Analisi della chinasi ERK in leucemia acuta mieloblastica e malattie linfoproliferative croniche 104
Synthesis, structure, spectroscopic properties and biological activity of mixed diorganotin(IV) complexes containing pyridine-2-carbaldehyde thiosemicarbazonato and diphenyldithiophosphinato ligands. 104
Ontogenesi dell'oncogene BCL2 in tessuti emopoietici fetali 104
The ontogenesis of BCL2 oncogene protein in human hemopoietic development 104
Synthesis, characterization, X-ray strucrure and biological activity of three new 5-formyluracil thiosemicarbazone complexes 104
Espressione dell'oncogene BCL2 in cellule emopoietiche fetali umane 104
Betulaceae, Corylaceae, Cupressaceae, Fagaceae and Salicaceae around Parma (Northern Italy): pollen calendars from 1995 to 1997 103
The reduction of the concentration of dust mites, mycophites and pollen grains in the indoor environment by means of an air purifier 103
Selective inhibition of MEK! Kinase downmodulates ERK activity and prolifaretion of acute myeloid leukemia blasts 103
Synthesis, spectroscopic characterization and biological properties of new natural aldehydes thiosemicarbazones 102
Role of GSTP1-1 in mediating the effect of As2O3 in the Acute Promyelocytic Leukemia cell line NB4. 102
Ontogenesis of signalling proteins:SHC, ERK, JNK expression and phosphorylation during human heart developpement 102
Hypoxia and Hypoxia Inducible Factor (HIF)-1α in Multiple Myeloma: Effect on the Pro-Angiogenic Signature of Myeloma Cells and the Bone Marrow Microenvironment. 101
Studio della trasduzione del segnale di attivazione cellulare attraverso l'espressione e la fosforilazione di SHC ed ERC chinasi 101
Constitutive expression and tyrosine phosphorylation of SHC proteins in chronic myelogenous leukemia 101
Riduzione della carica batterica aerodispersa mediante utilizzo di un purificatore d'aria in ambienti indoor 101
High levels of ERK constitutive activity in acute myelogenous leukemia 100
Blockade of Aurora kinases activity enhances APO2L/TRAIL sensitivity in multiple myeloma 100
Phorbol ester-induced PKC{epsilon} down-modulation sensitizes AML cells to TRAIL-induced apoptosis and cell differentiation. 100
Chimica, struttura ed attività biologica di sistemi metallo-legante solforato 100
Analisi dei meccansimi di attivazione di SHC, ERK e JNK in leucemia acuta mieloide 100
Totale 13.847
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.308
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.308
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022960 0 13 8 26 22 54 110 171 52 122 108 274
2022/20232.957 397 257 179 181 245 308 17 185 1.088 12 77 11
2023/20241.071 77 94 32 30 107 225 84 51 26 71 115 159
2024/20253.824 97 248 256 205 404 307 131 134 597 358 305 782
2025/20267.786 745 727 901 631 1.038 432 973 263 1.117 563 284 112
2026/2027524 174 350 0 0 0 0 0 0 0 0 0 0
Totale 23.106